English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Baylor College of Medicine

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

BCM researcher awarded grant to advance new ways to prevent and treat Alzheimer's disease

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Annual health checklist for older adults shared by Baylor College of Medicine expert

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Researchers identify mechanism driving pediatric brain tumor development in Nature study

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Researchers identify hormone-driven growth in lethal pediatric brain tumor

+ Pharmaceuticals
Patient Daily | Mar 24, 2026

Researchers identify new immune response mechanism with implications for cancer treatment

+ Pharmaceuticals
Patient Daily | Mar 23, 2026

Dr. Thomas Coffman to deliver Baylor College of Medicine commencement address in May

+ Pharmaceuticals
Patient Daily | Mar 20, 2026

Baylor College of Medicine celebrates Match Day as President Klotman prepares to retire

+ Pharmaceuticals
Patient Daily | Mar 19, 2026

Researchers find early weaning shapes gut immune system for lifelong health

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

  • 1
  • 2
  • 3
  • 4
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily